82 related articles for article (PubMed ID: 3432064)
21. [The analysis of left ventricular filling dynamics by radionuclide ventriculography using ECG's R wave and the second heart sound gating techniques].
Ishida Y; Inoue M; Matsumoto M; Fukushima M; Kim BH; Yamamoto K; Tsuneoka Y; Hiraoka T; Kimura K; Abe H
J Cardiogr; 1984 Jun; 14(1):75-84. PubMed ID: 6520428
[TBL] [Abstract][Full Text] [Related]
22. Combined first-pass and equilibrium radionuclide ventriculography for non-invasive quantification of aortic and/or mitral regurgitation--comparison with the left/right ventricular stroke count ratio.
Klepzig H; Standke R; Maul FD; Hör G; Kaltenbach M
Z Kardiol; 1986; 75 Suppl 2():24-7. PubMed ID: 3727693
[No Abstract] [Full Text] [Related]
23. The role of nuclear imaging in patients with acute myocardial infarction.
Williams BR
Prim Care; 1981 Sep; 8(3):399-413. PubMed ID: 7031730
[No Abstract] [Full Text] [Related]
24. [Predictive value of myocardial scintigraphy using Tc Sn(II)-pyrophosphate in relation to the time of development of acute precordial pain].
Cuarón A; Acero A; Cárdenas M
Arch Inst Cardiol Mex; 1982; 52(4):283-93. PubMed ID: 7138132
[No Abstract] [Full Text] [Related]
25. [Quantitative equilibrium radionuclide ventriculography at rest in the evaluation of the severity of coronary disease].
Knesewitsch P; Kleinhans E; Seiderer M; Doliwa R; Büll U
Nuklearmedizin; 1984 Feb; 23(1):41-6. PubMed ID: 6728693
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
[TBL] [Abstract][Full Text] [Related]
27. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
[TBL] [Abstract][Full Text] [Related]
28. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
[TBL] [Abstract][Full Text] [Related]
29. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity.
Steinberg JS; Wasserman AG
Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840
[TBL] [Abstract][Full Text] [Related]
30. [Radionuclide ventriculographic assessment of cardiac function based on the analysis of cardiac reserve during dynamic exercise].
Kim BH; Inoue M; Ishida Y; Tsuneoka Y; Hiraoka T; Fukushima M; Matsumoto M; Abe H; Minamino T
J Cardiogr Suppl; 1986; (8):33-42. PubMed ID: 3014016
[TBL] [Abstract][Full Text] [Related]
31. Fundamentals of equilibrium gated cardiac blood pool imaging.
Born ML
Clin Nucl Med; 1981 Oct; 6(10S):P122-30. PubMed ID: 6457718
[No Abstract] [Full Text] [Related]
32. Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity.
Pauwels EK; Horning SJ; Goris ML
Radiother Oncol; 1983 Aug; 1(1):83-7. PubMed ID: 6095370
[TBL] [Abstract][Full Text] [Related]
33. Selective right ventricular dysfunction following doxorubicin therapy.
Sperber AD; Cantor AA; Biran H; Keynan A
Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
[TBL] [Abstract][Full Text] [Related]
34. Comparison of methods for determining absolute left ventricular volumes from radionuclide ventriculography.
Warren SE; McKay RG; Aroesty JM; Heller GV; Kolodny GM; Royal HD
Am J Physiol Imaging; 1987; 2(1):24-32. PubMed ID: 3451764
[TBL] [Abstract][Full Text] [Related]
35. [Determination of ejection fraction and left ventricular fraction using isotopic ventriculography and bidimensional echocardiography. Comparison with contrast ventriculography].
Casáns Tormo I; Gómez Aldaravi R; Bodí Peris V; Sanchis Forés J; Ciudad Platero J; Insa Pérez L; Manjón Soriano J
Rev Esp Cardiol; 1998; 51 Suppl 1():10-8. PubMed ID: 9549395
[TBL] [Abstract][Full Text] [Related]
36. [Radionuclide ventriculography in the diagnosis of dilated cardiomyopathy].
Stroganova NP; Vysotskaia ZhM
Med Radiol (Mosk); 1990 Feb; 35(2):17-20. PubMed ID: 2156122
[TBL] [Abstract][Full Text] [Related]
37. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease.
Mahler DA; Brent BN; Loke J; Zaret BL; Matthay RA
Am Rev Respir Dis; 1984 Nov; 130(5):722-9. PubMed ID: 6388444
[TBL] [Abstract][Full Text] [Related]
38. [Possible prevention of adriamycin-induced cardiomyopathy by verapamil. Results of a pilot study].
Müllerleile U; Garbrecht M; Hanrath P; Langenstein BA; Bieber K; Bleifeld W; Hossfeld DK
Klin Wochenschr; 1984 Nov; 62(21):1032-7. PubMed ID: 6513433
[TBL] [Abstract][Full Text] [Related]
39. Monitoring cardiac function in patients receiving doxorubicin.
Lu P
Semin Nucl Med; 2005 Jul; 35(3):197-201. PubMed ID: 16098293
[TBL] [Abstract][Full Text] [Related]
40. [Cardiac risks of adriamycin. Early detection of high-risk patients by isotopic cardiac function study].
Pecking A; Delorme G; Berlie J; Goupil A; Tubiana M; Turpin F; Meeus L; Clavel B
Presse Med; 1983 Nov; 12(39):2445-8. PubMed ID: 6227889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
